Heutiger 8K: ih.advfn.com/p.php?pid=nmona&article=65315635
|
Zulassung von Fintepla verögert sich
www.fiercebiotech.com/biotech/...iling-for-rare-epilepsy-drug
Zogenix versucht den Zulassungsprozess zu beschleunigen
endpts.com/...plication-on-dravet-syndrome-drug-shares-spike/
Zogenix plant Übernahme von Modis Therapeutics
www.fiercebiotech.com/biotech/...-fda-breakthrough-tagged-med
www.fool.com/investing/2019/08/26/...ix-stock-sank-today.aspx
positive FINTEPLA® (LGS) Phase3 Studienergebnisse
zogenixinc.gcs-web.com/news-releases/...-global-pivotal-phase
endpts.com/...enix-lgs-trial-succeeds-but-results-underwhelm/
www.investors.com/news/technology/...h-company-lags-high-bar/
gute Studienergebnisse waren "nicht gut genug"
www.fool.com/investing/2020/02/07/...l-wasnt-positive-en.aspx
FDA verschiebt den PDUFA Termin um 3 Monate
"The FDA determined that the submission of this information constituted a major amendment to the NDA, resulting in this extension of the PDUFA goal date by three months."
zogenixinc.gcs-web.com/news-releases/...riod-finteplar-dravet
Zahlen für 2019
"The decrease in cash was primarily attributable to the $175.5 million used for the Modis acquisition on September 6, 2019."
zogenixinc.gcs-web.com/news-releases/...orts-fourth-quarter-3
200 Mio. $ Offering
zogenixinc.gcs-web.com/news-releases/...fering-common-stock-5
Zulassung für FINTEPLA®
zogenixinc.gcs-web.com/news-releases/...ne-treatment-seizures
Senior Notes Offering im Gespräch
zogenixinc.gcs-web.com/news-releases/...senior-notes-offering
200 Mio. $ Senior Notes Offering
zogenixinc.gcs-web.com/news-releases/...vertible-senior-notes
FINTEPLA® (fenfluramine) Zulassungsentscheidung in Europa noch in diesem Jahr geplant
"The European Commission (EC) is expected to make a final decision on the company’s Marketing Authorization Application (MAA) by the end of the year."
zogenixinc.gcs-web.com/news-releases/...inteplar-fenfluramine
Zahlen für Q3/20
zogenixinc.gcs-web.com/news-releases/...ts-third-quarter-2020
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
4 | 188 | ZGNX nächster Turnaroundwert mit großem Potential | thekey | Vassago | 19.01.22 11:28 |